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Abstract—N-Tosyl-5,5-divinyloxazolidin-2-one undergoes a palladium-catalyzed decarboxylative cyclization across a range of 
electrophilic alkenes to give the corresponding pyrrolidine derivatives bearing two contiguous quaternary centres. Alkenes bearing two 
electron withdrawing groups are required; pyrrolidines were not formed from mono-activated alkenes. Bulky, electron rich phosphines 
promote pyrrolidine formation with less highly electrophilic, doubly-activated alkenes, and a dramatic improvement is observed in the 
presence of iodide. © 2008 Elsevier Science. All rights reserved 
——— 
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1. Introduction 
Pyrrolidine-containing compounds display a wide variety 
of biological activities.1 Pyrrolidines have also been used 
extensively in chiral ligands and auxiliaries for asymmetric 
synthesis,2 and as highly effective scaffolds for the 
development of organocatalysts.3 Because of this, the 
synthesis of the pyrrolidine ring system has been the 
subject of much research. We were interested in developing 
a one-pot synthesis of pyrrolidines based on [3+2] 
cycloaddition of an activated alkene with a 1,3-dipole (Fig. 
1, path a) as an alternative to the more commonly used 
addition of azomethine ylides to activated alkenes4 (Fig 1, 
path b). 
Fig. 1 Construction of the pyrrolidine ring via [3+2] 
cycloaddition.  
In fact, this approach to the construction of the pyrrolidine 
ring, by cyclization across a carbon-carbon double bond to 
form the N-C1 and C2-C3 bonds has been accomplished 
previously using a range of different enophiles. These 
include the base-promoted addition of β-chloro-amines to 
enones;5 addition of allylic amines across electron rich 
alkenes mediated by palladium(II)6 or across acrylates 
mediated by base;7 formation of 3-
exomethylenepyrrolidines by cyclization of propargylic 
amines across electron poor alkenes, mediated by base,8 
copper (I)9 or palladium (0);10 Lewis acid mediated 
cyclization of α-amino aldehydes across allyl silanes11 or 
tandem Knoevenagel reaction of α-amino aldehydes 
followed by cyclization of the resulting highly electron-
deficient allylic amines across enol ethers.12 
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Fig. 2 Decarboxylative carbonylation of 5-vinyloxazolidin-
2-ones via a 1,3-dipole equivalent. 
We have reported13-15 the decarboxylative carbonylation of 
5-vinyloxazolidin-2-ones 1 as a stereocontrolled route to 
piperidines 2 and have used this reaction as the key step in 
the synthesis of polyhydroxylated piperidines such as 
deoxymannojirimycin and mannolactam.16 This reaction is 
proposed to proceed via a pi-allyl palladium(II) cation such 
as 3, which can be regarded, after loss of CO2, as an 
equivalent of the 1,3-dipole 4 (Fig. 2). This suggested the 
possibility of cycloaddition to suitably activated 
electrophilic alkenes, which would lead to pyrrolidines. In 
fact, 2-vinylaziridines 5 (R1 = alkyl) have been shown to 
undergo palladium-catalyzed ring-opening cyclization with 
a range of heterocumulenes such as such as carbodiimides, 
isothiocyanates, and isocyanates to give the corresponding 
five-membered heterocycles 6 (Fig. 3),17 and this reaction 
has been used as the basis for an enantioselective synthesis 
of imidazolidinones using a chiral palladium catalyst.18 
Yamamoto has reported the synthesis of pyrrolidines 7 by 
palladium-catalyzed addition of N-tosyl-2-vinylaziridines 5 
(R1 = Ts) to highly electrophilic alkenes19 and, since Ibuka 
has shown that N-sulfonyl-5-vinyloxazolidin-2-ones 8 are 
readily converted to the corresponding vinylaziridines 9 by 
palladium-catalyzed decarboxylation,20 this suggests that 
the more easily synthesized oxazolidinones might be used 
in place of aziridines for the preparation of pyrrolidine 
derivatives. In a similar way, Takemoto has reported the 
use of N-sulfonyloxazolidinones in place of the 
corresponding aziridines in a palladium-catalyzed synthesis 
of γ-amino alcohols.21 
Fig. 3 Palladium-catalyzed reactions involving 
vinylaziridines. 
In choosing a suitable dipolarophile, we were guided by the 
extensive reports of palladium-catalyzed tandem additions 
of a range of nucleophile/electrophile combinations to 
highly electron deficient alkylidene malonate derivatives.22 
Balme has reported the synthesis of exomethylene 
tetrahydrofurans and pyrrolidines by palladium-mediated 
cyclization of propargylic alcohols and amines across 
alkylidene malonates23 and has extended this to three-
component couplings terminated by metal-catalyzed 
arylation to give benzylidene pyrrolidines from propargylic 
amines.10b,f Yamamoto has used the palladium-catalyzed 
addition of vinyloxiranes to alkylidene malonates to form 
tetrahydrofurans24 and has reported an enantioselective 
variant based on the generation of similar hydroxyalkyl pi-
allyl palladium cationic intermediates from hydroxyalkyl 
allyl carbonates using Trost’s chiral ligand.25  
We have reported26 our preliminary investigation on the 
synthesis of highly substituted pyrrolidines via palladium-
catalyzed decarboxylative [3+2] cycloaddition of 5,5-
divinyl N-tosyloxazolidinones across alkylidene malonate 
derivatives and herein present the full details of this work. 
Recently, Tunge has reported the very closely analogous 
decarboxylative cyclization of 6-vinyloxazinanones with 
alkylidene malonates to give the corresponding 
vinylpiperidines.27
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2. Results and Discussion 
As the synthesis of pyrrolidines 7 from vinylaziridines 5 is 
reported to occur with low diastereoselectivity,19 we chose 
to use the achiral 5,5-divinyloxazolidinone 10 which avoids 
this issue as long as the two electron withdrawing groups 
on the alkene are identical. Oxazolidinone 10 was prepared 
in three steps from N-Boc glycine methyl ester (Scheme 1). 
Treatment of the amino ester with excess vinylmagnesium 
bromide gave the bisallylic alcohol 11 which, without 
purification, was cyclized to the oxazolidinone 12 by 
treatment with potassium tert-butoxide. Tosylation of the 
oxazolidinone nitrogen produced 10 in good yield. 
Scheme 1. Reagents and conditions: (a) CH2CHMgBr (2.5 
eq), THF, -78 oC to 20 oC, 4 h; (b) KOtBu, THF, 0 oC, 3 h, 
45% for two steps; (c) NaH, THF, 0 oC, then TsCl, 90%. 
The benzylidene Meldrum’s acid derivative 13a was used 
to investigate the optimum conditions for the reaction. We 
were pleased to find that treatment of the oxazolidinone 10 
with palladium tetrakis(triphenylphosphine) (10 mol%) 
followed by the alkene 13a at 40 oC gave the corresponding 
pyrrolidine 14a albeit in low yield (23%, Table 1, entry 1). 
In our work on carbonylation of N-tosyl 5-
vinyloxazolidinones we found that a reduction in the 
phosphine:palladium ratio was tolerated such that yields 
were essentially unchanged when just one phosphine per 
palladium was used.28 The results in Table 1 (entries 1 – 5) 
show that this is true here also. The yield of pyrrolidine 14a 
was essentially unchanged as the phosphorus:palladium 
ratio was reduced from 4:1 to 1:1, although no reaction was 
observed when triphenylphosphine was omitted altogether. 
It can also be seen that the yields are relatively independent 
of the nature of the palladium precursor: Pd(PPh3)4 (entry 
1), Pd2(dba)3 plus PPh3 (entry 5); and Pd2(dba)3.CHCl3 plus 
PPh3 (entries 2-4) all giving similar yields of pyrrolidinone. 
Scheme 2. Reagents and conditions: Pd2(dba)3.CHCl3 (5 
mol%), PPh3, 13 (1.5 eq), additive (2.0 eq), THF, 40 oC, 2 
h. 
A range of phosphines of varying steric and electronic 
properties, were screened (entries 6 – 11). 
Tributylphosphine and the chelating diphosphines dppb and 
dppf gave no product (the oxazolidinone was the major 
component visible in the NMR of the crude product 
mixture). Improvements in the yield of pyrrolidine were 
observed using the phosphite TMPP (entry 7) and the bulky 
electron rich 2-(dicyclohexylphosphino)biphenyl 15a (entry 
10), introduced by Buchwald29 for amination reactions. The 
even more bulky 2-(di-tert-butylphosphino)biphenyl 15b 
gave a poorer result (entry 11). Although the improvements 
in yield were encouraging, the relatively high cost of TMPP 
and 15a in comparison to triphenylphosphine makes these 
less attractive. 
The influence of added halide and acetate ions was then 
examined using triphenylphosphine as the ligand (entries 
12-16). Both fluoride and chloride ions inhibited the 
reaction and none of the pyrrolidine was observed (entries 
12 and 13). A dramatic improvement was observed when 
tetrabutylammonium bromide was used (67%, entry 14) 
and this was increased further still with iodide (77%, entry 
15). Acetate ions also promoted the reaction, but to a lesser 
extent than either bromide or iodide (42%, entry 16). 
Having established effective reaction conditions, we then 
investigated a variety of different electron-deficient 
coupling partners. The 3-cyanochromone 13b behaved in a 
similar way to the Meldrum’s acid derivative 13a in that 
cyclization occurred to give the corresponding pyrrolidine 
14b in moderate yield (38%, entry 17). In the presence of 
iodide, the yield was improved to 60% (entry 18) and use 
of a P:Pd ratio of 4 gave a slightly better yield than a ratio 
of 1 (63%, entry 19). The best yield (78%) was obtained by 
extending the reaction time to 18 h (entry 20). The use of a 
more electrophilic alkene, ethyl E-2-cyanocinnamate 13c 
gave the pyrrolidine 14c in 65% yield, essentially as a 
single diastereoisomer (entry 21). In this case the addition 
of iodide produced an almost identical yield (62%, entry 
22) with a reaction time of two hours, but this was 
improved (73%, entry 23) after 18 h. The yield was not 
further increased by using the bulky phosphine 15a (72%, 
entry 24). The stereochemistry of the pyrrolidine 14c was 
assigned on the basis of comparison of the chemical shift of 
the pyrrolidine 2-proton (5.51 ppm) which was much closer 
to the value (5.76 ppm) in the Meldrum’s acid derived 
product 14a in which the 2-H is syn to an ester than to 
those of the corresponding malononitrile-derived products 
14d-f (5.18 - 4.97 ppm), in which the 2-H is necessarily syn 
to a nitrile group. The stereochemical outcome can be 
explained on the basis of minimizing the steric interaction 
between the phenyl ring and the substituents (CO2Et and 
CN) on the 3-position of the pyrrolidine but would also 
arise if the cyclization occurred by a concerted syn-addition 
across the dipolarophile. 
The more highly activated arylidene malononitrile 
derivatives 13d-f gave excellent yields of the 
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corresponding pyrrolidines 14d-f (entries 25, 28, 31) and in 
these cases the addition of iodide led to lower yields 
(entries 26, 29, 32) which dropped even further with 
prolonged reaction times (entries 27, 30, 33). The 
benzylidene malononitrile 13d was recovered unchanged 
after treatment with tetrabutylammonium iodide in THF 
either in the presence or absence of Pd2(dba)3 and 
triphenylphosphine. The reason for the detrimental effect of 
iodide in these cases is unclear but probably involves 
further reactions of the initially formed pyrrolidine on 
extended reaction times. 
Attempts to use less activated Michael acceptors such as 
ethyl cinnamate, ethyl acrylate, acrylonitrile, maleic 
anhydride, phenyl vinyl sulfone, β-nitrostyrene, and 
dimethyl acetylenedicarboxylate were all unsuccessful. 
A possible catalytic cycle is shown in Scheme 3. Failure of 
the reaction when chelating diphosphines dppb and dppf 
were used suggests that at some stage of the mechanism 
palladium carries only one phosphine ligand. This may also 
be supported by the success of the reaction even when the 
phosphorus:palladium ratio is reduced from 4:1 to 1:1 and 
also by the improvement when the very bulky phosphine 
15a was used, since this ligand favours mono-phosphine pi-
allyl palladium(II) complexes.30 Electron rich phosphines, 
such as 15a are expected to accelerate the rate of the 
oxidative addition step and bulky ligands facilitate 
reductive elimination.29,31 Halide ions are well-known to 
affect the outcomes of transition metal catalyzed processes, 
including reactions involving pi-allyl palladium(II) 
species.32 Acceleration of the oxidative addition step, to 
form a pi-allyl palladium(II) intermediate may result from 
the increased nucleophilicity of (Ph3P)nPdX- species.32 
Halide ions are known to add to pi-allyl palladium(II) 
cations to set up an equilibrium with the corresponding η1-
bonded allyl comples.32 In this case, decarboxylation of the 
pi-allyl cation 16 may be slow due to a favourable 
intramolecular interaction between the palladium and the 
carbamate anion. Iodide-induced conversion of 16 into the 
σ-allyl 17 may facilitate the subsequent decarboxylation by 
disrupting this interaction. In a similar way, the conjugate 
addition of the pi-allyl cation 18 to the electrophile 13 may 
be retarded by stabilization of the amide anion by 
palladium; this interaction would also be reduced by 
formation of the corresponding σ-allyl complex 19. It is 
likely that the final, cyclization step occurs from a pi-allyl 
cation, such as 20, rather than the less electrophilic σ-allyl 
21. In our case, iodide proved to be the most effective 
halide additive, and this was especially evident in reactions 
of less reactive alkenes (13a-c) chloride ions were found to 
inhibit the present reaction completely (Table 1, entry 13). 
Given the improvement found using the bulky electron-rich 
phosphine 15a and iodide, steric factors may be important, 
either in favouring ligand dissociation, dissociation of co-
ordinated carbamate oxygen (from a species such as 16) 
which will facilitate decarboxylation, or reductive 
elimination in the cyclization step. 
The failure of reactions using less electrophilic alkenes 
suggests that the nucleophilicity of the nitrogen-based 
anion is important. While the strongly electron-
withdrawing tosyl group assists in the decarboxylation step, 
by stabilizing the resulting anion on nitrogen, this same 
stabilization will reduce the nucleophilicity of the anion 
and slow down the subsequent conjugate addition step. It 
may therefore be useful to explore less powerfully electron-
withdrawing substituents on nitrogen. Indeed, Yamamoto 
has recently reported a very effective intermolecular 
aminoallylation of activated alkenes using allyl carbamates 
in which the nitrogen atom bears a less electron 
withdrawing alkoxycarbonyl group.33 
In summary, we have developed an effective palladium-
catalyzed cyclization of the 5,5-divinyloxazolidinone 10 
across a range of electron deficient alkenes. Iodide 
promotes the reaction with less highly activated 
electrophiles and the cyclization generates pyrrolidines 14 
bearing two contiguous quaternary carbon atoms in good 
yields. 
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Scheme 3 Proposed catalytic cycle 
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3. Experimental 
3.1. General 
Melting points were determined on a Linkham TC92 hot 
stage and are uncorrected. Infrared spectra were recorded 
on a Nicolet 20 PCIR instrument.  Mass spectra were 
recorded on Micromass autospec M and Kratos MS80 RF 
spectrometers in electron impact (EI) mode.  1H NMR 
spectra were recorded on Bruker WM 300 (300 MHz), 
JEOL LA 500 (500 MHz) and Bruker AMX 500 (500 
MHz) spectrometers at ambient temperature. 13C NMR 
were recorded on Bruker WM 300 (75 MHz) and JEOL LA 
500 (125 MHz) spectrometers at ambient temperature. Thin 
layer chromatography was performed on EM reagent 0.25 
mm silica gel 60-F plates. Flash column chromatography 
was performed on Fluorochem LC3025 silica gel (40 – 63 
µm). All reactions were carried out under an atmosphere of 
nitrogen in pre-dried glassware unless otherwise stated. 
Where necessary, solvents were dried prior to use. 
Dichloromethane was distilled from calcium hydride under 
nitrogen immediately prior to use. Ethanol was distilled 
from magnesium under nitrogen and stored over 4Å 
molecular sieves. Ether and tetrahydrofuran were distilled 
from sodium/benzophenone ketyl immediately prior to use. 
All chemicals were purchased from the Aldrich, Fluka, 
Sigma, Strem or Lancaster chemical companies and were 
used as supplied except where indicated. The benzylidene 
Meldrum’s acid derivative 13a was prepared as previously 
described.34 
5,5-Divinyloxazolidin-2-one 12: To a stirred solution of N-
(tert-butoxycarbonyl)glycine methyl ester (10.06 g, 53.2 
mmol) in THF (500 mL) was added vinyl magnesium 
bromide (212 mL, 1 M solution in THF, 212 mmol) 
dropwise and the mixture was stirred at room temperature 
for 2 hours. The reaction was quenched with saturated 
aqueous ammonium chloride (100 mL) and the mixture was 
extracted with EtOAc (3 x 100 mL). The combined organic 
layers were washed with brine (2 x 100 mL), dried 
(MgSO4), filtered and the solvent removed under reduced 
pressure to give the crude bis allylic alcohol 11 as a light 
brown oil (10.89 g), which was used without further 
purification. 
For the crude product 11: δH (300 MHz, CDCl3) 5.88 (2H, 
dd, J = 10.7, 17.3 Hz, CH=CH2), 5.41 (2H, d, J = 17.3 Hz, 
CH=CH2), 5.20 (2H, d, J = 10.7 Hz, CH=CH2), 3.25 (2H, 
d, J = 6.2 Hz, NCH2), 1.43 (9H, s, tBu). 
To a stirred solution of the bis allylic alcohol 11 (10.89 g, 
51.1 mmol) in THF (500 mL) at 0 ºC was added KOtBu 
(6.87 g, 61.3 mmol) and the reaction mixture was stirred 
for 15 h. The solvent was removed under reduced pressure 
and the residue dissolved in ethyl acetate. The solution was 
washed with brine until the brine layer was clear. The 
organic layer was dried (MgSO4), filtered and the solvent 
was removed under reduced pressure. The crude product 
was purified by flash column chromatography (petrol / 
EtOAc, 1:1) to give the oxazolidinone 12 as a light brown 
oil (3.33 g, 45 % over two steps). δH (300 MHz, CDCl3) 
6.18 (1H, bs, NH), 5.88 (2H, dd, J = 10.7, 17.1 Hz, 
CH=CH2), 5.35 (2H, d, J = 17.1 Hz, HC=CHH), 5.24 (2H, 
d, J = 10.7 Hz, HC=CHH), 3.49 (2H, s, NCH2); δC (75 
MHz, CDCl3) 159.2, 136.8, 116.2, 83.5, 50.6, νmax/cm-1 
(film): 3292, 2989, 1754; m/z (EI+): 140 (M+, 11%), 112 
(20), 98 (8), 94 (24), 83 (77), 68 (54), 55 (90), 43 (19), 39 
(100); anal. calcd for C7H9NO2: C, 60.42; H, 6.52; N, 
10.07%, found: C, 60.96; H, 6.45; N, 9.62% 
3-(para-Toluenesulfonyl)-5,5-divinyloxazolidin-2-one 
10: To a suspension of sodium hydride (1.153 g, 60% 
dispersion in oil, 28.8 mmol) in THF (14 mL) and DMF 
(36 mL) at 0 ºC was added the 5,5-vinyloxazolidin-2-one 
12 (2.005 g, 14.4 mmol) and p-toluenesulphonyl chloride 
(3.571 g, 18.7 mmol) and the mixture was stirred overnight. 
The reaction mixture was cooled to -78 ºC, quenched with 
saturated ammonium chloride (50 mL) and extracted with 
ether (2 x 75 mL). The combined organic layers were 
washed with hydrochloric acid (50 mL, 2.0 M), saturated 
aqueous sodium hydrogen carbonate (50 mL), water (50 
mL) and brine (100 mL), dried (MgSO4), filtered and the 
solvent was removed under reduced pressure. The crude 
mixture was purified by flash column chromatography 
(petrol / EtOAc, 19:1, 9:1, 4:1) to give the oxazolidinone 
10 as a white solid (2.188 g, 90 %); m.p. 85 – 87 oC; δH 
(300 MHz, CDCl3) 7.95 (2H, d, J = 8.3 Hz, two of 
MeC6H4SO2), 7.41 (2H, d, J = 8.3 Hz, two of MeC6H4SO2), 
5.91 (2H, dd, J = 17.2, 10.8 Hz, CH=CH2), 5.43 (2H, d, J = 
17.2 Hz, HC=CHH), 5.36 (2H, d, J = 10.8 Hz, HC=CHH), 
3.95 (s, 2H, NCH2), 2.48 (s, 3H, CH3); δC (75 MHz, 
CDCl3) 151.3, 146.2, 135.4, 134.3, 130.3, 128.6, 118.3, 
81.9, 54.2, 22.1; νmax/cm-1 (KBr): 2923, 1776, 1363, 1169; 
m/z (EI+): 229 (M+ -64, 36%), 174 (8), 157 (6), 149 (83), 
139 (30), 119 (11), 108 (19), 91 (100), 79 (21), 65 (66), 56 
(87), 39 (24); anal. calcd for C14H15NO4S: C, 57.32; H, 
5.15; N, 4.77%: found: C, 57.40; H, 5.16; N, 4.78% 
Typical procedure for palladium catalyzed pyrrolidine 
formation: Pd2(dba)3.CHCl3 (41.4 mg, 0.04 mmol) was 
added to a stirred solution of the oxazolidinone 10 (234 mg, 
0.8 mmol), phosphine (0.08 – 0.32 mmol, depending on the 
reaction), and tetra-butylammonium salt (1.6 mmol, added 
in some cases, see Table) in THF (10 mL). The mixture 
was stirred at 40 oC for 20 min. and then a solution of the 
electrophilic alkene 13 (1.2 mmol) in THF (4 mL) was 
added dropwise. The resulting solution was stirred for 2 h, 
filtered through a plug of Celite, washing with 
dichloromethane, and the solvent was removed under 
reduced pressure. Purification by flash column 
chromatography (SiO2) eluting with petrol:EtOAc (5:1) 
gave the pyrrolidine 14. 
For the initial comparative study of Pd(PPh3)4 and 
Pd2(dba)3 with varying amounts of PPh3, yields were 
measured by 1H NMR as follows: the crude product was 
filtered through Celite, washing through with CH2Cl2 (30 
mL) and then the solvent was removed under reduced 
pressure. The resulting oil was dissolved in CDCl3 (2.0 
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mL). 250 µL of this solution was placed into an NMR tube 
and 250 µL of a solution of 1,3-dinitrobenzene [0.8 mmol 
in CDCl3 (2.0 mL)] was added. The resulting mixture was 
diluted with CDCl3 and the 1H NMR spectrum was 
recorded. The NMR yield was calculated from the relative 
integrals of the signals from 1,3-dinitrobenzene (δ 9.00, 
1H, H-2; δ 8.50, 2H, H-4) and the pyrrolidine product 14a. 
(δ 5.18-5.04, 3H, vinyl-H; δ 4.51, 1H, H-5; δ 4.02, 1H, H-
5). In the case of Table 1, entry 5, purification of the 
product resulted in an isolated yield of 18%, close to the 
NMR yield of 23%. 
8,8-Dimethyl-1-phenyl-2-(para-toluenesulfonyl)-4,4-
divinyl-7,9-dioxa-2-azaspiro[4.5]decane-6,10-dione 14a: 
white solid; m.p. 144 – 146 oC; δH (300 MHz, CDCl3) 7.58 
(2H, d, J = 8.4 Hz, ArH), 7.30-7.15 (7H, m, ArH), 5.76 
(1H, s, NCH), 5.72 (1H, dd, J = 17.4 Hz, 11.1 Hz, 
CH=CH2), 5.62 (1H, dd, J = 17.1 Hz, 10.5 Hz, CH=CH2), 
5.39 (1H, d, J = 11.1 Hz, CH=CHH), 5.18 (1H, d, J = 17.4 
Hz, CH=CHH), 5.13 (1H, d, J = 17.1 Hz, CH=CHH), 5.04 
(1H, d, J = 10.5 Hz, CH=CHH), 4.51 (1H, d, J = 10.9 Hz, 
NCH2), 4.02 (1H, d, J = 10.9 Hz, NCH2), 2.41 (3H, s, 
ArCH3), 1.51 (3H, s, CH3), 0.89 (3H, s, CH3); δC (125 
MHz, CDCl3) 165.2, 163.0, 143.8, 136.9, 136.4, 135.3, 
133.9, 129.7, 129.5, 128.8, 128.3, 128.1, 120.0, 117.4, 
105.6, 71.44, 68.1, 58.1, 56.9, 30.4, 28.3, 21.7; νmax/cm-1 
(KBr): 2924, 1774, 1742; m/z (EI+): 482 (M+, 55%), 449 
(50), 349 (96), 305 (100), 261 (54); found: (M+) 482.1623, 
C23H28NO6S requires: 482.1637. 
1,2,3,3a,4,9a-Hexahydro-4-oxo-1-(para-toluenesulfonyl)-
3,3-divinylchromeno[2,3-b]pyrrole-3a-carbonitrile 14b: 
white solid; m.p. 145 – 148 oC; δH (300 MHz, CDCl3) 7.80-
7.70 (3H, m, ArH), 7.50 (1H, apparent t, J = 7.8 Hz, ArH), 
7.29 (2H, d, J = 7.8 Hz, ArH), 7.02 (1H, t, J = 7.8 Hz, 
ArH), 6.94 (1H, d, J = 8.4 Hz, ArH), 6.17 (1H, dd, J = 17.4 
Hz, 10.8 Hz, CH=CH2), 6.08 (1H, s, NCH) 5.69 (1H, dd, J 
= 17.4 Hz, 10.8 Hz, CH=CH2), 5.33 (1H, d, J = 10.8 Hz, 
CH=CHH), 5.09 (1H, d, J = 17.4 Hz, CH=CHH), 5.06 (1H, 
d, J = 17.4 Hz, CH=CHH), 4.93 (1H, d, J = 10.8 Hz, 
CH=CHH), 3.74 (1H, d, J = 9.6 Hz, NCH2), 3.60 (1H, d, J 
= 9.6 Hz, NCH2), 2.36 (3H, s, CH3); δC (125 MHz, CDCl3) 
182.8, 159.3, 145.1, 138.2, 135.3, 135.2, 134.2, 130.3, 
128.2, 128.0, 127.7, 123.6, 120.1, 119.8, 119.2, 114.7, 
91.33, 60.3, 57.0, 54.2, 21.8; νmax/cm-1 (KBr): 2247, 1638, 
1644; m/z (EI+): 421 (M+, 20%), 208 (50); found: (M+ + H) 
421.1230, C23H21N2O4S requires: 421.1222. 
1-(para-Toluenesulfonyl)-3-cyano-3-ethoxycarbonyl-2-
phenyl-5,5-divinylpyrrolidine 14c: white prisms; m.p. 
102 – 103 oC; δH (300 MHz, CDCl3) 7.40 (2H, d, J = 6.6 
Hz, ArH), 7.30-7.10 (7H, m, ArH), 6.24 (1H, dd, J = 17.4 
Hz, 10.8 Hz, CH=CH2), 5.52 (1H, dd, J = 17.1 Hz, 10.8 Hz, 
CH=CH2), 5.51 (1H, s, NCH), 5.45 (1H, d, J = 10.8 Hz, 
CH=CHH), 5.38 (1H, d, J = 17.1 Hz, CH=CHH), 5.28 (2H, 
m, CH=CH2), 4.15 (1H, d, J = 11.5 Hz, NCH2), 4.25-4.00 
(2H, m, OCH2CH3), 3.95 (1H, d, J = 11.5 Hz, NCH2), 2.31 
(3H, s, ArCH3), 1.18 (3H, t, J = 7.1 Hz, OCH2CH3); δC 
(125 MHz, CDCl3) 163.7, 144.1, 136.6, 135.2, 134.9, 
133.7, 129.8, 129.2, 128.8, 128.4, 127.7, 120.0, 119.9, 
115.4, 66.8, 65.1, 63.9, 56.4, 55.7, 21.5, 14.4; νmax/cm-1 
(KBr): 2244, 1745, 1342, 1270, 1164, 1095, 1000; m/z 
(EI+): 450 (M+, 8%), 295 (95), 118 (100), 91 (65); found: 
(M+) 450.1607, C25H26N2O4S requires: 450.1613. 
1-(para-Toluenesulfonyl)-3,3-dicyano-2-phenyl-5,5-
divinylpyrrolidine 14d: white prisms; m.p. 99 – 101 oC; 
δH (300 MHz, CDCl3) 7.40-7.10 (9H, m, ArH), 6.04 (1H, 
dd, J = 17.4 Hz, 10.8 Hz, CH=CH2), 5.96 (1H, dd, J = 17.4 
Hz, 10.8 Hz, CH=CH2), 5.67 (1H, d, J = 17.4 Hz, 
CH=CHH), 5.62 (1H, d, J = 10.8 Hz, CH=CHH), 5.55 (1H, 
d, J = 10.8 Hz, CH=CHH), 5.40 (1H, d, J = 17.4 Hz, 
CH=CHH), 5.05 (1H, s, NCH), 4.45 (1H, d, J = 11.7 Hz, 
NCH2), 3.80 (1H, d, J = 11.7 Hz, NCH2), 2.32 (3H, s, 
CH3); δC (125 MHz, CDCl3) 143.0, 134.7, 133.4, 130.7, 
130.5, 129.7, 129.5, 128.6, 128.3, 127.2, 126.8, 126.1, 
120.9, 120.3, 67.9, 54.5, 52.7, 52.3, 21.7; νmax/cm-1 (KBr): 
2359, 2339, 1345, 1166; m/z (EI+): 403 (M+, 45%), 248 
(27), 118 (100), 91 (60); found: (M+) 403.1372, 
C23H21N3O2S requires: 403.1354. 
1-(para-Toluenesulfonyl)-3,3-dicyano-2-(4-
methoxyphenyl)-5,5-divinylpyrrolidine 14e: white 
prisms; m.p. 98 – 99 oC; δH (300 MHz, CDCl3) 7.40 (2H, d, 
J = 8.4 Hz, ArH), 7.04-7.02 (4H, m, ArH), 6.75 (2H, d, J = 
8.7 Hz, ArH), 6.04 (1H, dd, J = 17.4 Hz, 10.8 Hz, 
CH=CH2), 5.95 (1H, dd, J = 17.1 Hz, 10.8 Hz, CH=CH2), 
5.65 (1H, d, J = 17.1 Hz, CH=CHH), 5.61 (1H, d, J = 10.8 
Hz, CH=CHH), 5.54 (1H, d, J = 10.8 Hz, CH=CHH), 5.40 
(1H, d, J = 17.4 Hz, CH=CHH), 4.97 (1H, s, NCH), 4.31 
(1H, d, J = 11.8 Hz, NCH2), 3.82 (1H, d, J = 11.8 Hz, 
NCH2), 3.69 (3H, s, OCH3), 2.32 (3H, s, ArCH3); δC (125 
MHz, CDCl3) 165.2, 161.1, 144.7, 133.2, 132.3, 129.4, 
128.8, 127.7, 124.4, 124.0, 122.4, 121.8, 114.9, 113.8, 69.2, 
55.9, 55.7, 54.4, 53.8, 21.9; νmax/cm-1 (KBr): 2225, 1513, 
1278, 1180; m/z (EI+): 433 (M+, 50%), 278 (59), 184 (41), 
148 (100), 121 (38), 91 (41); found: (M+) 433.1472, 
C24H23N3O3S requires: 433.1460. 
1-(para-Toluenesulfonyl)-3,3-dicyano-2-(2-furyl)-5,5-
divinylpyrrolidine 14f: white prisms; m.p. 102 – 104 oC; 
δH (300 MHz, CDCl3) 7.45(2H, d, J = 8.1 Hz, ArH), 7.30-
7.20 (3H, m, ArH), 6.44 (1H, d, J = 3.3 Hz, ArH), 6.32 
(1H, dd, J = 3.3 Hz, 1.8 Hz, ArH), 6.07 (1H, dd, J = 17.4 
Hz, 10.8 Hz, CH=CH2), 5.97 (1H, dd, J = 17.4 Hz, 10.5 Hz, 
CH=CH2), 5.64 (1H, d, J = 17.4 Hz, CH=CHH), 5.64 (1H, 
d, J = 10.5 Hz, CH=CHH), 5.55 (1H, d, J = 10.8 Hz, 
CH=CHH), 5.41 (1H, d, J = 17.4 Hz, CH=CHH), 5.18 (1H, 
s, NCH), 4.21 (1H, d, J = 11.4 Hz, NCH2), 3.82 (1H, d, J = 
11.4 Hz, NCH2), 2.37 (3H, s, CH3); δC (125 MHz, CDCl3) 
144.9, 144.3, 135.6, 132.7, 131.9, 130.2, 129.7, 127.3, 
122.0, 121.7, 112.7, 111.4, 111.3, 111.0, 62.9, 55.8, 52.8, 
51.3, 21.6; νmax/cm-1 (KBr): 2356, 2339, 1357, 1164; m/z 
(EI+): 393 (M+, 7%), 238 (22), 108 (100), 91 (29); found: 
(M+) 393.1152, C21H19N3O3S requires: 393.1147. 
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Table 1. Palladium catalyzed decarboxylative cyclization of 5,5-divinyloxazolidin-2-one 10 with Michael acceptors 13 
 
Entry Michael Acceptor Phosphine P:Pda Additive Product Yieldb 
1 13a PPh3 4c — 14a 23d 
2 13a PPh3 4 — 14a 24d 
3 13a PPh3 2 — 14a 21d 
4 13a PPh3 1 — 14a 23d 
5 13a PPh3 1e — 14a 18d 
6 13a Bu3P 4 — 14a 0 
7 13a TMPPf 4 — 14a 35 
8 13a dppb 4 — 14a 0 
9 13a dppf 4 — 14a 0 
10 13a 2-Ph(C6H4)PCy2 (15a) 4 — 14a 36 
11 13a 2-Ph(C6H4)PtBu2 (15b) 4 — 14a 11 
12 13a PPh3 4 Bu4NF 14a 0 
13 13a PPh3 4 Bu4NCl 14a 0 
14 13a PPh3 4 Bu4NBr 14a 67 
15 13a PPh3 4 Bu4NI 14a 77 
16 13a PPh3 4 Bu4NOAc 14a 42 
17 13b PPh3 1 — 14b 38 
18 13b PPh3 1 Bu4NI 14b 60 
19 13b PPh3 4 Bu4NI 14b 63 
20 13b PPh3 4 Bu4NI 14b 78g 
21 13c PPh3 1 — 14c 65 
22 13c PPh3 4 Bu4NI 14c 62 
23 13c PPh3 4 Bu4NI 14c 73g 
24 13c 2-Ph(C6H4)PCy2 (15a) 4 Bu4NI 14c 72 
25 13d PPh3 1 — 14d 95 
26 13d PPh3 4 Bu4NI 14d 68 
27 13d PPh3 4 Bu4NI 14d 35g 
Ph O
O
O
O
TsN
Ph
O
OO
O
O
O
CN
O
O CN
N
Ts
CO2Et
CN
Ph
TsN
CO2Et
CNPh
CN
CN
Ph
TsN
CN
CNPh
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28 13e PPh3 1 — 14e 97 
29 13e PPh3 4 Bu4NI 14e 84 
30 13e PPh3 4 Bu4NI 14e 53g 
31 13f PPh3 1 — 14f 82 
32 13f PPh3 4 Bu4NI 14f 58 
33 13f PPh3 4 Bu4NI 14f 43g 
a
 Ratio of phosphorus:palladium in catalyst used. 
b
 Isolated yield. 
c
 Pd(PPh3)4 (10 mol%) was used in this case. 
d
 NMR yield, see Experimental section for details. 
e
 Pd2(dba)3 (5 mol%) was used in this case. 
f
 TMPP = trimethylolpropane phosphate 
e
 Reaction time was 18 h in this case. 
CN
CNMeO
TsN
CN
CN4-MeOC6H4
CN
CN
O
TsN
CN
CN
O
